Abbott Laboratories 2015 Annual Report Download - page 79

Some statements in this annual report may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Abbott cautions that these
forward-looking statements are subject to risks and uncertainties that may cause actual results to dier materially from those indicated in the forward-looking statements.
Economic, competitive, governmental, technological and other factors that may aect Abbott’s operations are discussed in Item 1A, “Risk Factors,” in our Securities and
Exchange Commission 2015 Form 10-K and are incorporated by reference. We undertake no obligation to release publicly any revisions to forward-looking statements as the
result of subsequent events or developments.
 Clinical studies have shown increased calcium absorption with 10 grams of FOS/Inulin proprietary blend per/day along with a calcium-enriched diet.
 A nger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial uid glucose levels may not accurately reect blood glucose levels
or if hypoglycaemia or impending hypoglycaemia is reported by the system or when symptoms do not match the system readings.
Abbott trademarks and products in-licensed by Abbott are shown in italics in the text of this report.
© 2016 Abbott Laboratories
e Abbott 2015 Annual Report was printed with the use of renewable wind power resulting in nearly zero
carbon emissions, keeping 16,425 pounds of CO2 from the atmosphere. is amount of wind-generated electricity
is equivalent to 14,251 miles not driven in an automobile or 1,187 trees planted. e Abbott Annual Report cover
and text is printed on recycled paper that contains a minimum of 10% post-consumer ber and the nancial
pages on 30% post-consumer ber.
STOCK LISTING
The ticker symbol for Abbott’s common
stock is ABT. The principal market for
Abbott’s common shares is the New York
Stock Exchange. Shares are also listed on
the Chicago Stock Exchange and traded on
various regional and electronic exchanges.
Outside the United States, Abbott’s shares
are listed on the London Stock Exchange
and the Swiss Stock Exchange.
QUARTERLY DIVIDEND DATES
Dividends are expected to be declared and
paid on the following schedule in 2016,
pending approval by the board of directors:
Quarter Declared Record Paid
First 2/19 4/15 5/16
Second 6/10 7/15 8/15
Third 9/15 10/14 11/15
Fourth 12/9 1/13/17 2/15/17
TAX INFORMATION FOR SHAREHOLDERS
Abbott is an Illinois High Impact
Business and is located in a U.S. federal
Foreign Trade Sub-Zone (Sub-Zone 22F).
Dividends may be eligible for a subtraction
from base income for Illinois income
tax purposes.
If you have any questions, please contact
your tax advisor.
DIVIDEND REINVESTMENT PLAN
The Abbott Dividend Reinvestment
Plan oers registered shareholders
an opportunity to purchase additional
shares, commission-free, through
automatic dividend reinvestment and/or
optional cash investments. Interested
persons may contact the transfer
agent, or call Abbott’s Investor Newsline.
DIVIDEND DIRECT DEPOSIT
Shareholders may have quarterly dividends
deposited directly into a checking or savings
account at any financial institution that
participates in the Automated Clearing
House system. For more information,
please contact the transfer agent, listed
below, right.
DIRECT REGISTRATION SYSTEM
In August 2008, Abbott implemented a
Direct Registration System (DRS) for all
registered shareholder transactions.
Shareholders will be sent a statement in
lieu of a physical stock certificate for
Abbott Laboratories stock. Please contact
the transfer agent with any questions.
ANNUAL MEETING
The annual meeting of shareholders will
be held at 9 a.m. on Friday, April 29, 2016,
at Abbott’s corporate headquarters.
Questions regarding the annual meeting
may be directed to the Corporate Secretary.
A copy of Abbott’s 2015 Form 10-K Annual
Report, as filed with the Securities and
Exchange Commission, is available on the
Abbott Web site at www.abbott.com or by
contacting the Investor Newsline.
CEO AND CFO CERTIFICATIONS
In 2015, Abbott’s chief executive ocer
(CEO) provided to the New York Stock
Exchange the annual CEO certification
regarding Abbott’s compliance with the
New York Stock Exchange’s corporate
governance listing standards. In addition,
Abbott’s CEO and chief financial ocer
filed with the U.S. Securities and Exchange
Commission all required certifications
regarding the quality of Abbott’s public
disclosures in its fiscal 2015 reports.
INVESTOR NEWSLINE
[phone]
INVESTOR RELATIONS
Dept. 362, AP6D2
Abbott
100 Abbott Park Road
Abbott Park, IL 60064-6400 U.S.A.
[phone]
SHAREHOLDER SERVICES
Computershare
P.O. Box 43078
Providence, RI 02940-3078
[phone] (U.S. or Canada)
[phone] (outside U.S. or Canada)
www.computershare.com
CORPORATE SECRETARY
Dept. 364, AP6D2
Abbott
100 Abbott Park Road
Abbott Park, IL 60064-6400 U.S.A.
[phone]
WEBSITE
www.abbott.com
ABBOTT ONLINE ANNUAL REPORT
www.abbott.com/annualreport
GLOBAL CITIZENSHIP REPORT
www.abbott.com/citizenship
TRANSFER AGENT AND REGISTRAR
Computershare
P.O. Box 43078
Providence, RI 02940-3078
[phone] (U.S. or Canada)
[phone] (outside U.S. or Canada)
www.computershare.com
SHAREHOLDER INFORMATION
Shareholders with questions about their
accounts may contact the transfer agent.
Individuals who would like to receive
additional information, or have questions
regarding Abbott’s business activities, may
call the Investor Newsline, write Abbott
Investor Relations, or visit Abbott’s Web site.
SHAREHOLDER AND CORPORATE INFORMATION